Eric Hall

Eric Hall, CFA, joined Gradalis as Chief Financial Officer in January 2023, after serving as interim CFO since August 2023. Eric has over 30 years of experience serving as Chief Financial Officer and Chief Operating Officer for a variety of public and private companies. For the past18 years, Mr. Hall has been a Partner of FLG Partners, LLC and a member of their Management Committee. He has extensive global experience in finance and has raised over $3 billion in debt and equity financing. He has been interim CFO for multiple life science companies, and since 2019, he has helped RAPT Therapeutics, ALX Oncology, Connect Biopharma, and Elevation Oncology in their IPOs. Mr. Hall is a Chartered Financial Analyst and member of the CFA Institute and the CFA Society of San Francisco.

He has an MBA in Finance from the Owen Graduate School of Management, Vanderbilt University, and a B.A. in Economics from the University of California at Davis.